
Danone’s CMO on adapting advertising as GLP-1 upends the food industry
The market for GLP-1 medication is estimated by several forecasters to bring in over $100 billion in annual revenue within the next decade. But the drug category, initially developed for diabetes but now widely used for weight loss, has also begun to …